Home HIV	FAQ My Amedeo About	Flying Publisher
	Amedeo Prize 2008 The 21 Finalists

Multiple Sclerosis

Free Subscription Articles published in J Neuroimmunol Retrieve available abstracts of 144 articles: HTML format

Single Articles

April 2008
1. RAMAGOPALAN SV , Dyment DA, Herrera BM, Deluca GC, et al
   Parental non-inherited HLA resistance alleles do not confer protection against multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
2. GRABER JJ , Allie SR, Mullen KM, Jones MV, et al
   Interleukin-17 in transverse myelitis and multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
3. VAKNIN-DEMBINSKY A , Murugaiyan G, Hafler DA, Astier AL, et al
   Increased IL-23 secretion and altered chemokine production by dendritic cells upon CD46 activation in patients with multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
4. MALMESTROM C , Lycke J, Haghighi S, Andersen O, et al
   Relapses in multiple sclerosis are associated with increased CD8(+) T-cell mediated cytotoxicity in CSF.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   March 2008
5. PAMPLIEGA O , Domercq M, Villoslada P, Sepulcre J, et al
   Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
6. WRAY BN , Stankovich J, Whittock L, Dwyer T, et al
   CTLA-4 and multiple sclerosis: The A49G single nucleotide polymorphism shows no association with multiple sclerosis in a Southern Australian population.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
7. COUTURIER N , Zappulla JP, Lauwers-Cances V, Uro-Coste E, et al
   Mast cell transcripts are increased within and outside multiple sclerosis lesions.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   February 2008
8. MATESANZ F , Fernandez O, Milne RL, Fedetz M, et al
   The high producer variant of the Fc-receptor like-3 (FCRL3) gene is involved in protection against multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   January 2008
9. CORREALE J , Villa A
   Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis.
   J Neuroimmunol. 2008;.
   PubMed     Related articles    Abstract available
   
   
   
10. KREMLEV SG , Gaurnier-Hausser AL, Del Valle L, Perez-Liz G, et al
    Angiocidin promotes pro-inflammatory cytokine production and antigen presentation in multiple sclerosis.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
11. LINDBERG RL , Achtnichts L, Hoffmann F, Kuhle J, et al
    Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
12. SMOLDERS J , Damoiseaux J, Menheere P, Hupperts R, et al
    Vitamin D as an immune modulator in multiple sclerosis, a review.
    J Neuroimmunol. 2008;.
    PubMed     Related articles    Abstract available
    
    
    
13. MILWARD E , Kim KJ, Szklarczyk A, Nguyen T, et al
    Cleavage of myelin associated glycoprotein by matrix metalloproteinases.
    J Neuroimmunol. 2008;193.
    PubMed     Related articles    Abstract available
    
    
    December 2007
14. ROOS IM , Kockum I, Hillert J
    The interleukin 23 receptor gene in multiple sclerosis: A case-control study.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
15. CHEN Z , Freedman MS
    Correlation of specialized CD16(+) gammadelta T cells with disease course and severity in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
16. O'CONNOR RA , Anderton SM
    Foxp3(+) regulatory T cells in the control of experimental CNS autoimmune disease.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
17. PUISSANT-LUBRANO B , Viala F, Winterton P, Abbal M, et al
    Thymic output and peripheral T lymphocyte subsets in relapsing-remitting multiple sclerosis patients treated or not by IFN-beta.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
18. GILLI F , Marnetto F, Caldano M, Valentino P, et al
    Anti-interferon-beta neutralising activity is not entirely mediated by antibodies.
    J Neuroimmunol. 2007;192.
    PubMed     Related articles    Abstract available
    
    
    November 2007
19. D'AGUANNO S , Barassi A, Lupisella S, d'eril GM, et al
    Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
20. MIROWSKA-GUZEL D , Mach A, Gromadzka G, Czlonkowski A, et al
    BDNF A196G and C270T gene polymorphisms and susceptibility to multiple sclerosis in the polish population. Gender differences.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
21. CROXFORD JL , Pryce G, Jackson SJ, Ledent C, et al
    Cannabinoid-mediated neuroprotection, not immunosuppression, may be more relevant to multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
22. SATTLER MB , Togni M, Gadjanski I, Suhs KW, et al
    Strain-specific susceptibility for neurodegeneration in a rat model of autoimmune optic neuritis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
23. MOLDOVAN IR , Cotleur AC, Zamor N, Butler RS, et al
    Multiple sclerosis patients show sexual dimorphism in cytokine responses to myelin antigens.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
24. WINGES KM , Gilden DH, Bennett JL, Yu X, et al
    Analysis of multiple sclerosis cerebrospinal fluid reveals a continuum of clonally related antibody-secreting cells that are predominantly plasma blasts.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
25. FAINARDI E , Rizzo R, Melchiorri L, Stignani M, et al
    Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting Multiple Sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
26. WILLENBORG DO , Staykova M
    Reglation of neuroinflammation.
    J Neuroimmunol. 2007;191.
    PubMed     Related articles   
    
    
    
27. WEISS HA , Millward JM, Owens T
    CD8+ T cells in inflammatory demyelinating disease.
    J Neuroimmunol. 2007;191.
    PubMed     Related articles    Abstract available
    
    
    
28. SEGAL BM
    The role of natural killer cells in curbing neuroinflammation.
    J Neuroimmunol. 2007;191.
    PubMed     Related articles    Abstract available
    
    
    October 2007
29. URCELAY E , Blanco-Kelly F, de Las Heras V, de la Concha EG, et al
    TLR4 haplotypes in multiple sclerosis: A case-control study in the Spanish population.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
30. CORREALE J , Farez M
    Monocyte-derived dendritic cells in multiple sclerosis: The effect of bacterial infection.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
31. MUZIO L , Martino G, Furlan R
    Multifaceted aspects of inflammation in multiple sclerosis: The role of microglia.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
32. ASTIER AL , Hafler DA
    Abnormal Tr1 differentiation in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
33. PENDER MP
    Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
34. STUART R , Lovett-Racke AE, Frohman EM, Hawker K, et al
    Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
35. LUNDMARK F , Duvefelt K, Hillert J
    Genetic association analysis of the interleukin 7 gene (IL7) in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
36. PACHNER AR , Brady J, Narayan K
    Antibody-secreting cells in the central nervous system in an animal model of MS: Phenotype, association with disability, and in vitro production of antibody.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles    Abstract available
    
    
    
37. PRINCE HE , Lape-Nixon M, Audette C, Van Horn K, et al
    Identification of interferon-beta antibodies in a reference laboratory setting: findings for 1144 consecutive sera.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles    Abstract available
    
    
    
38. DYMENT DA , Ebers GC
    Microsatellites and genome scans-- a GAMES postscript.
    J Neuroimmunol. 2007;190.
    PubMed     Related articles   
    
    
    September 2007
39. FRISULLO G , Mirabella M, Angelucci F, Caggiula M, et al
    The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
40. BYNOE MS , Bonorino P, Viret C
    Control of experimental autoimmune encephalomyelitis by CD4(+) suppressor T cells: Peripheral versus in situ immunoregulation.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available   Free Full Text
    
    
    
41. BUTTMANN M , Merzyn C, Hofstetter HH, Rieckmann P, et al
    TRAIL, CXCL10 and CCL2 plasma levels during long-term Interferon-beta treatment of patients with multiple sclerosis correlate with flu-like adverse effects but do not predict therapeutic response.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
42. VAN VEEN T , Nielsen J, Berkhof J, Barkhof F, et al
    CCL5 and CCR5 genotypes modify clinical, radiological and pathological features of multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
43. RIVEROL M , Sepulcre J, Fernandez-Alonso M, Uccelli A, et al
    Antibodies against Epstein-Barr virus and herpesvirus type 6 are associated with the early phases of Multiple Sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles   
    
    
    
44. GLADSTONE DE , Golightly MG, Brannagan TH 3rd
    High dose cyclophosphamide preferentially targets naive T (CD45/CD4/RA+) cells in CIDP and MS patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
45. GIBBS E , Oger J
    The IgG subclass-specificities of anti-IFNbeta antibodies change with time and differ between the IFNbeta products in relapsing remitting multiple sclerosis patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
46. KRUMBHOLZ M , Theil D, Steinmeyer F, Cepok S, et al
    CCL19 is constitutively expressed in the CNS, up-regulated in neuroinflammation, active and also inactive multiple sclerosis lesions.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    August 2007
47. IMAM SA , Guyton MK, Haque A, Vandenbark A, et al
    Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
48. O'DOHERTY C , Roos IM, Antiguedad A, Aransay AM, et al
    ITGA4 polymorphisms and susceptibility to multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
49. BRUM DG , Barreira AA, Louzada-Junior P, Mendes-Junior CT, et al
    Association of the HLA-DRB1()15 allele group and the DRB1()1501 and DRB1()1503 alleles with multiple sclerosis in White and Mulatto samples from Brazil.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    July 2007
50. KOSMACZEWSKA A , Bilinska M, Ciszak L, Noga L, et al
    Different patterns of activation markers expression and CD4+ T-cell responses to ex vivo stimulation in patients with clinically quiescent multiple sclerosis (MS).
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
51. ZIVKOVIC M , Djuric T, Dincic E, Raicevic R, et al
    Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
52. STEWART N , Taylor B, Ponsonby AL, Pittas F, et al
    The effect of season on cytokine expression in multiple sclerosis and healthy subjects.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
53. SARCHIELLI P , Di Filippo M, Candeliere A, Chiasserini D, et al
    Expression of ionotropic glutamate receptor GLUR3 and effects of glutamate on MBP- and MOG-specific lymphocyte activation and chemotactic migration in multiple sclerosis patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
54. CAPRA R , Sottini A, Cordioli C, Serana F, et al
    IFNbeta bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
55. MARTINEZ A , Mas A, de Las Heras V, Bartolome M, et al
    FcRL3 and multiple sclerosis pathogenesis: Role in autoimmunity?
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
56. CANNELLA B , Gaupp S, Omari KM, Raine CS, et al
    Multiple sclerosis: Death receptor expression and oligodendrocyte apoptosis in established lesions.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
57. GAVALAS E , Kountouras J, Deretzi G, Boziki M, et al
    Helicobacter pylori and multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles   
    
    
    
58. KANTOR AB , Deng J, Waubant E, Lin H, et al
    Identification of short-term pharmacodynamic effects of interferon-beta-1a in multiple sclerosis subjects with broad- based phenotypic profiling.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
59. ANDREOLI V , Cittadella R, Valentino P, Condino F, et al
    The role of VLA4 polymorphisms in multiple sclerosis: An association study.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
60. JACOB A , Matiello M, Wingerchuk DM, Lucchinetti CF, et al
    Neuromyelitis optica: changing concepts.
    J Neuroimmunol. 2007;187.
    PubMed     Related articles    Abstract available
    
    
    June 2007
61. WEINSTOCK-GUTTMAN B , Zivadinov R, Tamano-Blanco M, Abdelrahman N, et al
    Immune cell BDNF secretion is associated with white matter volume in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
62. GERHAUSER I , Alldinger S, Baumgartner W
    Ets-1 represents a pivotal transcription factor for viral clearance, inflammation, and demyelination in a mouse model of multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
63. AIRAS L , Nikula T, Huang YH, Lahesmaa R, et al
    Postpartum-activation of multiple sclerosis is associated with down-regulation of tolerogenic HLA-G.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    May 2007
64. FABRIEK BO , Moller HJ, Vloet RP, van Winsen LM, et al
    Proteolytic shedding of the macrophage scavenger receptor CD163 in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
65. HEGGARTY S , Suppiah V, Silversides J, O'doherty C, et al
    CTLA4 gene polymorphisms and multiple sclerosis in Northern Ireland.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
66. JACOBI C , Lange P, Reiber H
    Quantitation of intrathecal antibodies in cerebrospinal fluid of subacute sclerosing panencephalitis, herpes simplex encephalitis and multiple sclerosis: Discrimination between microorganism-driven and polyspecific immune response.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
67. GARG N , Zivadinov R, Ramanathan M, Vasiliu I, et al
    Clinical and MRI correlates of autoreactive antibodies in multiple sclerosis patients.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
68. GOLD R , Jawad A, Miller DH, Henderson DC, et al
    Expert opinion: Guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
69. KALMAN B , Laitinen K, Komoly S
    The involvement of mitochondria in the pathogenesis of multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
70. BRUDEK T , Luhdorf P, Christensen T, Hansen HJ, et al
    Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
71. CASTELLI L , Comi C, Chiocchetti A, Nicola S, et al
    ICOS gene haplotypes correlate with IL10 secretion and multiple sclerosis evolution.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
72. LAMBRACHT-WASHINGTON D , O'Connor KC, Cameron EM, Jowdry A, et al
    Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.
    J Neuroimmunol. 2007;186.
    PubMed     Related articles    Abstract available
    
    
    
73. VAN WINSEN LM , Hooper-van Veen T, van Rossum EF, Koper JW, et al
    Glucocorticoid receptor gene polymorphisms associated with more aggressive disease phenotype in MS.
    J Neuroimmunol. 2007;186.
    PubMed     Related articles    Abstract available
    
    
    March 2007
74. COMABELLA M , Martin R
    Genomics in multiple sclerosis-Current state and future directions.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
75. RAMAGOPALAN SV , Deluca GC, Morrison KM, Herrera BM, et al
    No effect of APOE and PVRL2 on the clinical outcome of multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
76. PACHNER AR , Li L, Narayan K
    Intrathecal antibody production in an animal model of multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    February 2007
77. SOTGIU S , Sannella AR, Conti B, Arru G, et al
    Multiple sclerosis and anti-Plasmodium falciparum innate immune response.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
78. GRABER JJ , Ford D, Zhan M, Francis G, et al
    Cytokine changes during interferon-beta therapy in multiple sclerosis: Correlations with interferon dose and MRI response.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
79. KANTENGWA S , Weber MS, Juillard C, Benkhoucha M, et al
    Inhibition of naive Th1 CD4(+) T cells by glatiramer acetate in multiple sclerosis.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    
80. LI W , Minohara M, Su JJ, Matsuoka T, et al
    Helicobacter pylori infection is a potential protective factor against conventional multiple sclerosis in the Japanese population.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    January 2007
81. AKTAS O , Waiczies S, Zipp F
    Neurodegeneration in autoimmune demyelination: Recent mechanistic insights reveal novel therapeutic targets.
    J Neuroimmunol. 2007;.
    PubMed     Related articles    Abstract available
    
    
    December 2006
82. PETERSON LK , Fujinami RS
    Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
83. OLIVER B , Mayorga C, Fernandez V, Leyva L, et al
    Interferon receptor expression in multiple sclerosis patients.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
84. DIEM R , Sattler MB, Bahr M
    Neurodegeneration and -protection in autoimmune CNS inflammation.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
85. CUNNINGHAM S , O'doherty C, Patterson C, McDonnell G, et al
    The neuropeptide genes TAC1, TAC3, TAC4, VIP and PACAP(ADCYAP1), and susceptibility to multiple sclerosis.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
86. HARP C , Lee J, Lambracht-Washington D, Cameron E, et al
    Cerebrospinal fluid B cells from multiple sclerosis patients are subject to normal germinal center selection.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
87. CID C , Regidor I, Alcazar A
    Anti-heat shock protein 90beta antibodies are detected in patients with multiple sclerosis during remission.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
88. DE ANDRES C , Aristimuno C, de Las Heras V, Martinez-Gines ML, et al
    Interferon beta-1a therapy enhances CD4(+) regulatory T-cell function: An ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    November 2006
89. WEINSTOCK-GUTTMAN B , Tamano-Blanco M, Bhasi K, Zivadinov R, et al
    Pharmacogenetics of MXA SNPs in interferon-beta treated multiple sclerosis patients.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
90. CHRISTENSEN T , Petersen T, Thiel S, Brudek T, et al
    Gene-environment interactions in multiple sclerosis: Innate and adaptive immune responses to human endogenous retrovirus and herpesvirus antigens and the lectin complement activation pathway.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
91. HAEGELE KF , Stueckle CA, Malin JP, Sindern E, et al
    Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controls.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
92. DRESSEL A , Vogelgesang A, Brinkmeier H, Mader M, et al
    Glatiramer acetate-specific human CD8+ T cells: Increased IL-4 production in multiple sclerosis is reduced by glatiramer acetate treatment.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
93. REINDL M , Khalil M, Berger T
    Antibodies as biological markers for pathophysiological processes in MS.
    J Neuroimmunol. 2006;180.
    PubMed     Related articles    Abstract available
    
    
    
94. GIOVANNONI G , Chapman MD, Thompson EJ
    The role of antibody affinity for specific antigens in the differential diagnosis of inflammatory nervous system disorders.
    J Neuroimmunol. 2006;180.
    PubMed     Related articles    Abstract available
    
    
    October 2006
95. KRAKAUER M , Sorensen PS, Sellebjerg F
    CD4+ memory T cells with high CD26 surface expression are enriched for Th1 markers and correlate with clinical severity of multiple sclerosis.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
96. LUTTEROTTI A , Kuenz B, Gredler V, Khalil M, et al
    Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
97. GRONEN F , Ruprecht K, Weissbrich B, Klinker E, et al
    Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
98. LUNDMARK F , Harbo HF, Celius EG, Saarela J, et al
    Association analysis of the LAG3 and CD4 genes in multiple sclerosis in two independent populations.
    J Neuroimmunol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
99. JENSEN J , Langkilde AR, Frederiksen JL, Sellebjerg F, et al
    CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
    J Neuroimmunol. 2006;179.
    PubMed     Related articles    Abstract available
    
    
    September 2006
100. KUMAR M , Putzki N, Limmroth V, Remus R, et al
     CD4(+)CD25(+)FoxP3(+) T lymphocytes fail to suppress myelin basic protein-induced proliferation in patients with multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
101. MIKOL DD , Ditlow C, Usatin D, Biswas P, et al
     Serum IgE reactive against small myelin protein-derived peptides is increased in multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
102. RATTS RB , Lovett-Racke AE, Choy J, Northrop SC, et al
     CD28-CD57+ T cells predominate in CD8 responses to glatiramer acetate.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     
103. MI W , Prentice TW, Young CR, Johnson RR, et al
     Restraint stress decreases virus-induced pro-inflammatory cytokine mRNA expression during acute Theiler's virus infection.
     J Neuroimmunol. 2006;178.
     PubMed     Related articles    Abstract available
     
     
     August 2006
104. LINK H , Huang YM
     Oligoclonal bands in multiple sclerosis cerebrospinal fluid: An update on methodology and clinical usefulness.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
105. BIEGLER BW , Yan SX, Ortega SB, Tennakoon DK, et al
     Glatiramer acetate (GA) therapy induces a focused, oligoclonal CD8+ T-cell repertoire in multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
106. THE GAMES COLLABORATIVE GROUP
     Linkage disequilibrium screening for multiple sclerosis implicates JAG1 and POU2AF1 as susceptibility genes in Europeans.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
107. ANTEL J , Bar-Or A
     Roles of immunoglobulins and B cells in multiple sclerosis: From pathogenesis to treatment.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
108. RUS H , Cudrici C, Niculescu F, Shin ML, et al
     Complement activation in autoimmune demyelination: Dual role in neuroinflammation and neuroprotection.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
109. CROSS AH , Stark JL, Lauber J, Ramsbottom MJ, et al
     Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available   Free Full Text
     
     
     
110. JULIA E , Montalban X, Al-Zayat H, Issazadeh-Navikas S, et al
     Deficient Fas expression by CD4+ CCR5+ T cells in multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
111. RATTS RB , Karandikar NJ, Hussain RZ, Choy J, et al
     Phenotypic characterization of autoreactive T cells in multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
112. LEES JR , Archambault AS, Russell JH
     T-cell trafficking competence is required for CNS invasion.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
113. JANKE AD , Giuliani F, Yong VW
     IVIg attenuates T cell-mediated killing of human neurons.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
114. SIEVE AN , Steelman AJ, Young CR, Storts R, et al
     Sex-dependent effects of chronic restraint stress during early Theiler's virus infection on the subsequent demyelinating disease in CBA mice.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     
115. HEINE S , Ebnet J, Maysami S, Stangel M, et al
     Effects of interferon-beta on oligodendroglial cells.
     J Neuroimmunol. 2006;177.
     PubMed     Related articles    Abstract available
     
     
     July 2006
116. PENG X , Jin J, Giri S, Montes M, et al
     Immunomodulatory effects of 3-hydroxy-3-methylglutaryl coenzyme-A reductase inhibitors, potential therapy for relapsing remitting multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
117. WILLER CJ , Herrera BM, Morrison KM, Sadovnick AD, et al
     Association between microchimerism and multiple sclerosis in Canadian twins.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
118. MINOHARA M , Matsuoka T, Li W, Osoegawa M, et al
     Upregulation of myeloperoxidase in patients with opticospinal multiple sclerosis: Positive correlation with disease severity.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
119. TOMMASI C , Petit-Teixeira E, Cournu-Rebeix I, Caponi L, et al
     PADI4 gene in multiple sclerosis: A family-based association study.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
120. DHIB-JALBUT S , Arnold DL, Cleveland DW, Fisher M, et al
     Neurodegeneration and neuroprotection in multiple sclerosis and other neurodegenerative diseases.
     J Neuroimmunol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
121. XU J , Chavis JA, Racke MK, Drew PD, et al
     Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes.
     J Neuroimmunol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     
122. VYSHKINA T , Kalman B
     Analyses of a MS-associated haplotype encompassing the CCL3 gene.
     J Neuroimmunol. 2006;176.
     PubMed     Related articles    Abstract available
     
     
     June 2006
123. AIRAS L , Mikkola J, Vainio JM, Elovaara I, et al
     Elevated serum soluble vascular adhesion protein-1 (VAP-1) in patients with active relapsing remitting multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
124. LAPLAUD DA , Berthelot L, Miqueu P, Bourcier K, et al
     Serial blood T cell repertoire alterations in multiple sclerosis patients; correlation with clinical and MRI parameters.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
125. VANDERLOCHT J , Hendriks JJ, Venken K, Stinissen P, et al
     Effects of IFN-beta, leptin and simvastatin on LIF secretion by T lymphocytes of MS patients and healthy controls.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
126. CALDERON TM , Eugenin EA, Lopez L, Kumar SS, et al
     A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: Regulation of CXCL12 expression in astrocytes by soluble myelin basic protein.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
127. DINCIC E , Zivkovic M, Stankovic A, Obradovic D, et al
     Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian population.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
128. BASILE E , Gibbs E, Aziz T, Oger J, et al
     During 3 years treatment of primary progressive multiple sclerosis with glatiramer acetate, specific antibodies switch from IgG1 to IgG4.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
129. HARBO HF , Ekstrom PO, Lorentzen AR, Sundvold-Gjerstad V, et al
     Coding region polymorphisms in T cell signal transduction genes. Prevalence and association to development of multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
130. WILSON HC , Scolding NJ, Raine CS
     Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
131. PELFREY CM , Cotleur AC, Zamor N, Lee JC, et al
     Immunological studies of mitoxantrone in primary progressive MS.
     J Neuroimmunol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
132. JOHNSON RR , Prentice TW, Bridegam P, Young CR, et al
     Social stress alters the severity and onset of the chronic phase of Theiler's virus infection.
     J Neuroimmunol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     
133. MALMESTROM C , Andersson BA, Haghighi S, Lycke J, et al
     IL-6 and CCL2 levels in CSF are associated with the clinical course of MS: implications for their possible immunopathogenic roles.
     J Neuroimmunol. 2006;175.
     PubMed     Related articles    Abstract available
     
     
     May 2006
134. DU PASQUIER RA , Stein MC, Lima MA, Dang X, et al
     JC virus induces a vigorous CD8(+) cytotoxic T cell response in multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
135. MIROWSKA-GUZEL DM , Kurowska K, Skierski J, Koronkiewicz M, et al
     High dose of intravenously given glucocorticosteroids decrease IL-8 production by monocytes in multiple sclerosis patients treated during relapse.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
136. BREIJ EC , Heijnen P, van der Goes A, Teunissen CE, et al
     Myelin flow cytometry assay detects enhanced levels of antibodies to human whole myelin in a subpopulation of multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
137. NAVARRO J , Aristimuno C, Sanchez-Ramon S, Vigil D, et al
     Circulating dendritic cells subsets and regulatory T-cells at multiple sclerosis relapse: Differential short-term changes on corticosteroids therapy.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
138. SANTOS R , Weinstock-Guttman B, Tamano-Blanco M, Badgett D, et al
     Dynamics of interferon-beta modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-beta neutralizing antibodies.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
139. LOPEZ C , Comabella M, Al-Zayat H, Tintore M, et al
     Altered maturation of circulating dendritic cells in primary progressive MS patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     
140. GNEISS C , Tripp P, Ehling R, Khalil M, et al
     Interferon-beta antibodies have a higher affinity in patients with neutralizing antibodies compared to patients with non-neutralizing antibodies.
     J Neuroimmunol. 2006;174.
     PubMed     Related articles    Abstract available
     
     
     
141. KHALIL M , Reindl M, Lutterotti A, Kuenz B, et al
     Epitope specificity of serum antibodies directed against the extracellular domain of myelin oligodendrocyte glycoprotein: Influence of relapses and immunomodulatory treatments.
     J Neuroimmunol. 2006;174.
     PubMed     Related articles    Abstract available
     
     
     April 2006
142. GORIS A , Maranian M, Walton A, Yeo TW, et al
     CD24 Ala/Val polymorphism and multiple sclerosis.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     March 2006
143. SATOH JI , Nakanishi M, Koike F, Onoue H, et al
     T cell gene expression profiling identifies distinct subgroups of Japanese multiple sclerosis patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     
     January 2006
144. MARTINEZ A , de Las Heras V, Mas Fontao A, Bartolome M, et al
     An IFNG polymorphism is associated with interferon-beta response in Spanish MS patients.
     J Neuroimmunol. 2006;.
     PubMed     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

This AMEDEO Service was made possible thanks to the generous unrestricted educational grants provided by Bayer Schering Pharma AG.

Amedeo is a Bernd Sebastian Kamps website.    Design: